Although data about the contribution of FOXP3+ Tregs in the pathogenesis of primary glomerulopathies and systematic autoimmune diseases of native kidneys are scarce, they imply that endogenous FOXP3+ Tregs reduction may negatively impact renal injury progression. Here, FOXP3 is linked to lipoprotein glomerulopathy.